Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients

NCT07717788 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal
Statin Therapy

Interventions

DRUG: Alendronate 70 mg tablets
DRUG: Atorvastatin
DRUG: Rosuvastatin

Sponsor

Alkufa university\\collage of pharmacy